SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
- PMID: 10559916
- DOI: 10.1038/12013
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Abstract
Degradation of the mammalian cyclin-dependent kinase (CDK) inhibitor p27 is required for the cellular transition from quiescence to the proliferative state. The ubiquitination and subsequent degradation of p27 depend on its phosphorylation by cyclin-CDK complexes. However, the ubiquitin-protein ligase necessary for p27 ubiquitination has not been identified. Here we show that the F-box protein SKP2 specifically recognizes p27 in a phosphorylation-dependent manner that is characteristic of an F-box-protein-substrate interaction. Furthermore, both in vivo and in vitro, SKP2 is a rate-limiting component of the machinery that ubiquitinates and degrades phosphorylated p27. Thus, p27 degradation is subject to dual control by the accumulation of both SKP2 and cyclins following mitogenic stimulation.
Similar articles
-
PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).Curr Biol. 2001 Feb 20;11(4):263-7. doi: 10.1016/s0960-9822(01)00065-3. Curr Biol. 2001. PMID: 11250155
-
The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.Biochem Biophys Res Commun. 2001 Mar 9;281(4):884-90. doi: 10.1006/bbrc.2001.4442. Biochem Biophys Res Commun. 2001. PMID: 11237742
-
The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.Nat Cell Biol. 2001 Mar;3(3):321-4. doi: 10.1038/35060126. Nat Cell Biol. 2001. PMID: 11231585
-
Deregulated degradation of the cdk inhibitor p27 and malignant transformation.Semin Cancer Biol. 2003 Feb;13(1):41-7. doi: 10.1016/s1044-579x(02)00098-6. Semin Cancer Biol. 2003. PMID: 12507555 Review.
-
Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors.Methods Mol Biol. 2000;142:109-23. doi: 10.1385/1-59259-053-5:109. Methods Mol Biol. 2000. PMID: 10806617 Review. No abstract available.
Cited by
-
Ubiquitin ligases in cancer: Functions and clinical potentials.Cell Chem Biol. 2021 Jul 15;28(7):918-933. doi: 10.1016/j.chembiol.2021.04.008. Epub 2021 May 10. Cell Chem Biol. 2021. PMID: 33974914 Free PMC article. Review.
-
A Dynamical Framework for the All-or-None G1/S Transition.Cell Syst. 2016 Jan 27;2(1):27-37. doi: 10.1016/j.cels.2016.01.001. Epub 2016 Jan 27. Cell Syst. 2016. PMID: 27136687 Free PMC article.
-
The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.Cell Cycle. 2015;14(16):2688-700. doi: 10.1080/15384101.2015.1056946. Cell Cycle. 2015. PMID: 26038816 Free PMC article.
-
Tumor suppressor protein Lgl mediates G1 cell cycle arrest at high cell density by forming an Lgl-VprBP-DDB1 complex.Mol Biol Cell. 2015 Jul 1;26(13):2426-38. doi: 10.1091/mbc.E14-10-1462. Epub 2015 May 6. Mol Biol Cell. 2015. PMID: 25947136 Free PMC article.
-
Identification of small molecule inhibitors of p27(Kip1) ubiquitination by high-throughput screening.Cancer Sci. 2013 Nov;104(11):1461-7. doi: 10.1111/cas.12246. Epub 2013 Sep 6. Cancer Sci. 2013. PMID: 23910095 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous